SCOPUS 정보 검색 플랫폼

Journal of Pharmacy and Pharmacology

Volumn 53, Issue 6, 2001, Pages 831-839

Synthesis of potential aldose reductase inhibitors based on minimal pharmacophore requirements

(3) Schlitzer, M a Rodriguez, L b Kador, P F b

a PHILIPPS UNIVERSITY MARBURG (Germany)

b NATIONAL EYE INSTITUTE (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDEHYDE REDUCTASE; ALDOSE REDUCTASE INHIBITOR; DIMETHYL SULFOXIDE; N 2 NAPHTHYLACETYL BETA ALANINE; N 3 (2 NAPHTHYL)ACRYLOYL GLYCINE METHYL ESTER; N 3 (2 PHENYL THIAZOLE 4 YL)ACRYLOYL ALANINE; N 3 (2 PHENYL THIAZOLE 4 YL)ACRYLOYL BETA ALANINE; N 3 (2 PHENYL THIAZOLE 4 YL)ACRYLOYL GLYCINE; N 3 (2 PHENYL THIAZOLE 4 YL)ACRYLOYL GLYCINE METHYL ESTER; N 3 [5 (2 NITROPHENYL)FURAN 2 YL]ACRYLOYL GLYCINE; N 3 [5 (2 NITROPHENYL)FURAN 2 YL]ACRYLOYL GLYCINE METHYL ESTER; N 3 [5 (2 NITROPHENYL)FURAN 2 YL]ACRYLOYL PHENYLALANINE; N [4 (6 METHYLBENZOTHIAZOLE 2 YL)PHENYL]GLUTARAMIC ACID; N [4 (6 METHYLBENZOTHIAZOLE 2 YL)PHENYL]MALONAMIC ACID METHYL ESTER; N [4 (6 METHYLBENZOTHIAZOLE 2 YL)PHENYL]SUCCINAMIC ACID; N [4 (6 METHYLBENZOTHIAZOLE 2 YL)PHENYL]SUCCINAMIC ACID METHYL ESTER; N BENZOTHIAZOLE 2 YL GLUTARAMIC ACID; N BENZOTHIAZOLE 2 YL GLUTARAMIC ACID METHYL ESTER; N BENZOTHIAZOLE 2 YL SUCCINAMIC ACID; N BENZOTHIAZOLE 2 YL SUCCINAMIC ACID METHYL ESTER; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG STRUCTURE; DRUG SYNTHESIS; ENZYME ASSAY; ENZYME INHIBITION; ENZYME PURIFICATION; PHARMACOPHORE; PHYSICAL CHEMISTRY;

ALDEHYDE REDUCTASE; CARBOXYLIC ACIDS; DRUG DESIGN; ENZYME INHIBITORS; ESTERS; HUMANS; METHYLATION; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0034986359 PISSN: 00223573 EISSN: None Source Type: Journal
DOI: 10.1211/0022357011776180 Document Type: Article

Times cited : (15)

References (11)

1
- 0000248247
- The Knoevenagel condensation
- In: Cope, A. C. (ed.); John Wiley & Sons, Inc., New York
- (1967) Organic Reactions , vol.15
- Jones, G.¹

2
- 0023881428
- Medicinal chemistry of aldose reductase inhibitors
- (1988) Med. Res. Rev. , vol.8 , pp. 159-186
- Larson, E.R.¹ Lipinski, C.A.² Sarges, R.³

3
- 0028219573
- Molecular modeling studies of aldose reductase
- (1994) J. Med. Chem. , vol.37 , pp. 787-792
- Lee, Y.S.¹ Pearlstein, R.² Kador, P.F.³

4
- 0031727488
- Molecular modeling studies of the binding modes of aldose reductase inhibitors at the active site of human aldose reductase
- (1998) Bioorg. Med. Chem. , vol.6 , pp. 1811-1819
- Lee, Y.S.¹ Chen, Z.² Kador, P.F.³

5
- 0023899991
- The role of aldose reductase in the development of diabetic complications
- (1988) Med. Res. Rev. , vol.8 , pp. 325-352
- Kador, P.F.¹

6
- 0021828899
- Aldose reductase inhibitors: A potential new class of agents for the pharmacological control of certain diabetic complications
- (1985) J. Med. Chem. , vol.28 , pp. 841-849
- Kador, P.F.¹ Kinoshita, J.H.² Sharpless, N.E.³

7
- 0025279099
- In vitro expression of rat lens aldose reductase in Escherichia coli
- (1990) Proc. Natl Acad. Sci. USA , vol.87 , pp. 4942-4945
- Old, S.E.¹ Sato, S.² Kador, P.F.³ Carper, D.A.⁴

8
- 0024811440
- Aldose reductase inhibitors: Structure-activity relationships and therapeutic potential
- In: Testa, B. (ed.); Academic Press Ltd, London
- (1989) Advanced Drug Research , vol.18 , pp. 139-175
- Sarges, R.¹

9
- 0025171028
- Inhibition of aldehyde reductase by aldose reductase inhibitors
- (1990) Biochem. Pharmacol. , vol.40 , pp. 1033-1042
- Sato, S.¹ Kador, P.F.²

10
- 0026700495
- Aldose reductase inhibitors and diabetic complications
- (1992) Pharmacol. Ther. , vol.54 , pp. 151-194
- Tomlinson, D.R.¹ Willars, G.B.² Carrington, A.L.³

11
- 0031920049
- Aldose reductase in glucose toxicity: A potential target for the prevention of diabetic complications
- (1998) Pharmacol. Rev. , vol.50 , pp. 21-33
- Yabe-Nishimura, C.¹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.